Found: 12
Select item for more details and to access through your institution.
Adjuvant Endocrine Therapy in Premenopausal Women With Operable Breast Cancer: Understanding the Issues.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 4, p. 331
- By:
- Publication type:
- Article
Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 3, p. 207, doi. 10.1093/jnci/djm289
- By:
- Publication type:
- Article
Re-evaluating Adjuvant Breast Cancer Trials: Assessing Hormone Receptor Status by Immunohistochemical Versus Extraction Assays.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 21, p. 1571, doi. 10.1093/jnci/djj415
- By:
- Publication type:
- Article
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Present and future projects of the international breast cancer study group.
- Published in:
- Cancer (0008543X), 1994, v. 74, n. S3, p. 1139, doi. 10.1002/1097-0142(19940801)74:3+<1139::AID-CNCR2820741524>3.0.CO;2-K
- By:
- Publication type:
- Article
Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93.
- Published in:
- 2013
- By:
- Publication type:
- Report
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
- Published in:
- Breast Cancer Research, 2016, v. 18, p. 1, doi. 10.1186/s13058-016-0771-8
- By:
- Publication type:
- Article
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Adjuvant ovarian function suppression and cognitive function in women with breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparing aromatase inhibitors in the absence of clinical trial results can be misleading.
- Published in:
- Journal of Surgical Oncology, 2007, v. 95, n. 4, p. 355, doi. 10.1002/jso.20710
- By:
- Publication type:
- Article
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 6, p. 441, doi. 10.1093/jnci/djs125
- By:
- Publication type:
- Article